Biopharmaceutical leader in the development of treatments for rare diseases
Monitoring the implementation of the Patient Protection and Affordable Care Act, including provisions related to regulatory pathway for biosimilars and orphan drugs.
Education and outreach on treatment of rare diseases to Congressional staff.
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX (House Rules Comm Assoc, Subcomm Staff Dir.)
House Rules Comm Assoc, Subcomm Staff Dir.